Results 111 to 120 of about 69,806 (216)

Fighting HIV/AIDS: Reconfiguring the State? [PDF]

open access: yes, 2008
The author wishes to thank the anonymous reviewers of the article and the ESRC for funding part of this ...
AIDS Campaign Team for Africa (ACTAfrica)   +9 more
core   +1 more source

Biologically Younger Individuals, as Identified by MARK‐AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of Age

open access: yesAging Cell, Volume 25, Issue 3, March 2026.
Using sets of biomarkers of human ageing, a ‘bioage’ score was established allowing calculation of ‘age difference’ (bioage minus chronological age). Age difference, but not chronological age, was correlated with levels of HDL, Vitamin D, and CD3+ CD4+/CD45+ ratio, with biologically younger subjects displaying favourable values, pointing to a role of ...
María Moreno‐Villanueva   +52 more
wiley   +1 more source

Efficacy of antituberculosis therapy in combination with antiretroviral therapy in patients with co-infection TB/HIV [PDF]

open access: yesMedičnì Perspektivi, 2013
Changes towards worsening of epidemiologic situation as for tuberculosis in a great extent are caused by spread of HIV-infection among population of Ukraine.
Kryzhanovsky D.G., Marchenko N.A.
doaj  

In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

open access: yesPLoS ONE, 2012
Endogenous serine protease inhibitors (serpins) are anti-inflammatory mediators with multiple biologic functions. Several serpins have been reported to modulate HIV pathogenesis, or exhibit potent anti-HIV activity in vitro, but the efficacy of serpins ...
Mohammed Asmal   +6 more
doaj   +1 more source

Targeting MCL‐1 and MAPK overcomes venetoclax resistance in FLT3‐ITD‐positive AML cells harbouring activating PTPN11 (SHP‐2) mutations

open access: yesBritish Journal of Haematology, Volume 208, Issue 3, Page 905-915, March 2026.
Summary Venetoclax (VEN)‐based therapies have improved the treatment of acute myeloid leukaemia (AML); however, the emergence of resistance remains a major limitation. Mutations in protein tyrosine phosphatase (PTP) non‐receptor type 11 (PTPN11) and FMS like tyrosine kinase 3 with internal tandem duplication (FLT3‐ITD) are common in resistant patients ...
Maximilian Fleischmann   +12 more
wiley   +1 more source

Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants

open access: yesClinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Zoliflodacin is a first‐in‐class oral spiropyrimidinetrione antibiotic being developed for patients with uncomplicated gonorrhea, including those infected with multidrug‐resistant strains. Because zoliflodacin is metabolized by cytochrome P450 3A4 (CYP3A4), concomitant administration with a CYP3A inhibitor has the potential to increase ...
Alison Luckey   +10 more
wiley   +1 more source

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial

open access: yesJournal of Virus Eradication
Objective: Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury.
Jasmini Alagaratnam   +18 more
doaj   +1 more source

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

open access: yesPLoS ONE, 2015
Cancer cells have a high iron requirement and many experimental studies, as well as clinical trials, have demonstrated that iron chelators are potential anti-cancer agents.
Eliška Potůčková   +14 more
doaj   +1 more source

Cooperative research and development opportunities with the National Cancer Institute [PDF]

open access: yes
The Office of Technology Development (OTD) of the National Cancer Institute (NCI) is responsible for negotiating Cooperative Research and Development Agreements (CRADAs), whereby the knowledge resulting from NCI investigators' government-sponsored ...
Sybert, Kathleen
core   +1 more source

Utilização dos registros de dispensação da farmácia como indicador da não-adesão à terapia anti-retroviral em indivíduos infectados pelo HIV Pharmacy records as an indicator of non-adherence to antiretroviral therapy by HIV-infected patients

open access: yesCadernos de Saúde Pública, 2009
Este estudo teve como objetivos avaliar os registros de dispensação de anti-retrovirais (ARV) por um período de 12 meses após a primeira prescrição e determinar os fatores associados com a retirada irregular ou abandono em dois serviços públicos de ...
Raquel Regina de Freitas Magalhães Gomes   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy